Biochimica et Biophysica Acta-Reviews on Cancer

Article	Citations
Tumour cell-induced platelet aggregation in breast cancer: Scope of metal nanoparticles	371
Microbial influence on triggering and treatment of host cancer: An intestinal barrier perspective	253
Modeling bladder cancer in the laboratory: Insights from patient-derived organoids	187
Nutrition and dietary restrictions in cancer prevention	183
miRNAs and androgen deprivation therapy for prostate cancer	154
TSPAN1, a novel tetraspanin member highly involved in carcinogenesis and chemoresistance	153
The interaction of SET and protein phosphatase 2A as target for cancer therapy	126
Is tumour-expressed aminopeptidase N (APN/CD13) structurally and functionally unique?	104
Advances in epigenetic modifications and cervical cancer research	104
Reflections on drug resistance to KRAS inhibitors and gene silencing/editing tools for targeting mutant KRAS in cancer treatment	99
ESR1 activating mutations: From structure to clinical application	98
Uveal melanoma modeling in mice and zebrafish	93
Progress and challenges of immunotherapy in triple-negative breast cancer	87
Decoding the role of FOXP3 in esophageal cancer: Underlying mechanisms and therapeutic implications	79
Contribution of CXCR3-mediated signaling in the metastatic cascade of solid malignancies	78
Transcription factors in glioblastoma – Molecular pathogenesis and clinical implications	74
Extracellular vesicles in cancer therapy: Roles, potential application, and challenges	72
In what area of biology has a “new” type of cell death been discovered?	69
Epigenetic changes associated with Bacillus Calmette-Guerin (BCG) treatment in bladder cancer	69
Prostate cancer: Molecular aspects, consequences, and opportunities of the multifocal nature	63
Biomarkers in high grade serous ovarian cancer	63
Advances and prospects of mRNA vaccines in cancer immunotherapy	61
Dual perspective on autophagy in glioma: Detangling the dichotomous mechanisms of signaling pathways for therapeutic insights	61
S100A8 and S100A9 in Cancer	58
Insights into the role of connexins and specialized intercellular communication pathways in breast cancer: Mechanisms and applications	56

Long non-coding RNAs: Fundamental regulators and emerging targets of cancer stem cells	53
Fascin-1 in primary liver cancers, perspectives for targeted therapy	52
Targeting lipid metabolism in cancer metastasis	49
Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting	47
Recent insights into RNA m5C methylation modification in hepatocellular carcinoma	46
Prognostic features of the tumour microenvironment in oesophageal adenocarcinoma	46
Enhancing the anti-tumor response by combining DNA damage repair inhibitors in the treatment of solid tumors	46
Long non-coding RNAs: A view to kill ovarian cancer	45
Small non-coding RNAs and pancreatic ductal adenocarcinoma: Linking diagnosis, pathogenesis, drug resistance, and therapeutic potential	45
Multiple impacts of Naa10p on cancer progression: Molecular functions and clinical prospects	45
Multifaceted roles of neutrophils in tumor microenvironment	45
Multiple therapeutic approaches of glioblastoma multiforme: From terminal to therapy	45
The interplay of obesity, microbiome dynamics, and innovative anti-obesity strategies in the context of endometrial cancer progression and therapeutic approaches	45
Targeting Cdc20 for cancer therapy	45
Interleukin-21 as an adjuvant in cancer immunotherapy: Current advances and future directions	43
Antibody-drug conjugates in HER-2 negative breast cancers with poor prognosis	42
Editorial Board	42
Nondiploid cancer cells: Stress, tolerance and therapeutic inspirations	42
Epithelial-Mesenchymal Transition in Cancer: A Focus on Itraconazole, a Hedgehog Inhibitor	42
Current advances in comprehensive omics data mining for oncology and cancer research	41
Vagus innervation in the gastrointestinal tumor: Current understanding and challenges	41
Matrisomics: Beyond the extracellular matrix for unveiling tumor microenvironment	41
Intestinal multicellular organoids to study colorectal cancer	40
Unveiling the potential of gene editing techniques in revolutionizing Cancer treatment: A comprehensive overview	39
Platinum-based systematic therapy in triple-negative breast cancer	39
Refinement of safety and efficacy of anti-cancer chemotherapeutics by tailoring their site-specific intracellular bioavailability through transporter modulation	39
The emerging roles of dual-specificity phosphatases and their specific characteristics in human cancer	39
Antibody-drug conjugates in breast cancer: Marching from HER2-overexpression into HER2-low	38
ASPORIN: A root of the matter in tumors and their host environment	38
Ubiquitination/de-ubiquitination: A promising therapeutic target for PTEN reactivation in cancer	38
In vitro anticancer properties of anthocyanins: A systematic review	37
Implications of viral infection in cancer development	36
A role for RIO kinases in the crosshair of cancer research and therapy	36
Focus on mast cells in the tumor microenvironment: Current knowledge and future directions	36
Predictive and prognostic value of PIK3CA mutations in HER2-positive breast cancer treated with tyrosine kinase inhibitors: A systematic review and meta-analysis	36
Cross talk between autophagy and oncogenic signaling pathways and implications for cancer therapy	35
The Pleiotropic role, functions and targeted therapies of LIF/LIFR axis in cancer: Old spectacles with new insights	35
Modulation of N-glycosylation in the PD-1: PD-L1 axis as a strategy to enhance cancer immunotherapies	35
Muscle-to-tumor crosstalk: The effect of exercise-induced myokine on cancer progression	35
CD8+ T-cell exhaustion: Impediment to triple-negative breast cancer (TNBC) immunotherapy	34
An overview of BAP1 biological functions and current therapeutics	34
Mesenchymal stem cells in glioblastoma therapy and progression: How one cell does it all	34
Advances in clinical immunotherapy for gastric cancer	33
Cellular functions, molecular signalings and therapeutic applications: Translational potential of deubiquitylating enzyme USP9X as a drug target in cancer treatment	33
Abnormal metabolism in hepatic stellate cells: Pandora's box of MAFLD related hepatocellular carcinoma	32
HOXA1, a breast cancer oncogene	32
Overview of splicing variation in ovarian cancer	32
Emerging strategies to overcome PARP inhibitors' resistance in ovarian cancer	31
Exosomal non-coding RNAs (ncRNAs) as potential biomarkers in tumor early diagnosis	31
Carbonic anhydrase IX: An atypical target for innovative therapies in cancer	31

Schwann cells and enteric glial cells: Emerging stars in colorectal cancer	30
Dual role of Snail1 as transcriptional repressor and activator	30
Directing CAR T cells towards the tumor vasculature for the treatment of solid tumors	30
Unraveling molecular aberrations and pioneering therapeutic strategies in osteosarcoma	30
Exploring the gut microbiome: A potential biomarker for cancer diagnosis, prognosis, and therapy	29
RUNX1 and cancer	29
Colorectal cancer: Metabolic interactions reshape the tumor microenvironment	29
Manipulating macrophage polarization in cancer patients: From nanoparticles to human chimeric antigen receptor macrophages	29
A holistic view on c-Kit in cancer: Structure, signaling, pathophysiology and its inhibitors	28
SNARE proteins: Core engines of membrane fusion in cancer	28
New target DDR1: A “double-edged sword” in solid tumors	28
Strategies for studying immune and non-immune human and canine mammary gland cancer tumour infiltrate	28
Interleukin-1 signaling in solid organ malignancies	28
USP7 - a crucial regulator of cancer hallmarks	28
Data-driven approaches to advance research and clinical care for pediatric cancer	28
A novel approach to reducing disparities in health outcomes by enhancing interpretation of cancer clinical trials for underrepresented patient groups	28
Stress granules dynamics and promising functions in pancreatic cancer	27
New insight into the role of SMAD4 mutation/deficiency in the prognosis and therapeutic resistance of pancreatic ductal adenocarcinomas	27
To kill a cancer: Targeting the immune inhibitory checkpoint molecule, B7-H3	27
Potentially diagnostic and prognostic roles of piRNAs/PIWIs in pancreatic cancer: A review	27
Scientific and clinical relevance of non-cellular tumor microenvironment components in ovarian cancer chemotherapy resistance	27
Proteomics of post-translational modifications in colorectal cancer: Discovery of new biomarkers	27
Keep your eyes peeled for long noncoding RNAs: Explaining their boundless role in cancer metastasis, drug resistance, and clinical application	27
Augmentation of the EPR effect by mild hyperthermia to improve nanoparticle delivery to the tumor	26
From resistance to resilience: Uncovering chemotherapeutic resistance mechanisms; insights from established models	26
Perspectives and mechanisms for targeting mitotic catastrophe in cancer treatment	26
Artificial intelligence and allied subsets in early detection and preclusion of gynecological cancers	26
Role of F-box proteins in human upper gastrointestinal tumors	26
Keratin 1 as a cell-surface receptor in cancer	26
Epigenetic regulation of cancer-associated fibroblast heterogeneity	25
Consequence of distinctive expression of MUC2 in colorectal cancers: How much is actually bad?	25
A special subtype: Revealing the potential intervention and great value of KRAS wildtype pancreatic cancer	25
The correlation between gut and intra-tumor microbiota and PDAC: Etiology, diagnostics and therapeutics	24
Improving DCIS diagnosis and predictive outcome by applying artificial intelligence	24
Research progress of mitochondria and cytoskeleton crosstalk in tumour development	24
The clinical significance and correlative signaling pathways of paired box gene 9 in development and carcinogenesis	24
Overcoming therapeutic resistance in pancreatic cancer: Emerging opportunities by targeting BRCAs and p53	24
Dual roles of human endogenous retroviruses in cancer progression and antitumor immune response	24
A digital highway for data fluidity and data equity in precision medicine	24
Emerging roles of PIWI-interacting RNAs (piRNAs) and PIWI proteins in head and neck cancer and their potential clinical implications	23
Spatiotemporal heterogeneity and clinical challenge of pancreatic neuroendocrine tumors	23
Non-small cell lung cancer: Emerging molecular targeted and immunotherapeutic agents	23
Epidermal growth factor receptor PROTACs as an effective strategy for cancer therapy: A review	23
Expression and function of NF-Y subunits in cancer	23
Understanding the role of DNA methylation in colorectal cancer: Mechanisms, detection, and clinical significance	23
Role of Yin Yang 1 (YY1) on microenvironment, signaling pathways, and epigenetics in lung cancer	22
Editorial Board	22
Finding the junction between claudins and endometrial carcinoma	22
Clinical considerations of CDK4/6 inhibitors in triple-negative breast cancer	22
Machine Learning in Epigenomics: Insights into Cancer Biology and Medicine	22
Tumoral heterogeneity in neuroblastoma	22
Epigenetic therapy: Research progress of decitabine in the treatment of solid tumors	22
The interplay between microbiome and host factors in pathogenesis and therapy of head and neck cancer	22
The neoantigens derived from transposable elements – A hidden treasure for cancer immunotherapy	22
Histone deacetylase complexes: Structure, regulation and function	22
Reflecting on the cardiac toxicity in non-small cell lung cancer in the era of immune checkpoint inhibitors therapy combined with thoracic radiotherapy	22
Changing landscape of anti-angiogenic therapy: Novel approaches and clinical perspectives	22
B7-H3 regulates anti-tumor immunity and promotes tumor development in colorectal cancer	22
Role of the intratumoral microbiome in tumor progression and therapeutics implications	22
βIII-tubulin overexpression in cancer: Causes, consequences, and potential therapies	21
CD95 (Fas) and CD95L (FasL)-mediated non-canonical signaling pathways	21
Clinical and Molecular Attributes and Evaluation of Pancreatic Cystic Neoplasm	21
Tumor microenvironment diversity and plasticity in cancer multidrug resistance	21
Editorial Board	21
Centrosome amplification in cancer and cancer-associated human diseases	21
Psychological intervention to treat distress: An emerging frontier in cancer prevention and therapy	21
The signaling pathways regulated by KRAB zinc-finger proteins in cancer	21
Advances in tuft cells, a chemosensory cell in sequential diseases of the pancreas	21
Cancer-associated fungi: An emerging powerful player in cancer immunotherapy	20
Advances in glioma models using in vivo electroporation to highjack neurodevelopmental processes	20
Roles of K(H)SRP in modulating gene transcription throughout cancer progression: Insights from cellular studies to clinical perspectives	20
GSDM family and glioma	20
Enhancing immune checkpoint blockade therapy of genitourinary malignancies by co-targeting PMN-MDSCs	20
The role of exosomes in the tumour microenvironment on macrophage polarisation	20
The comparison of pathogenic role and mechanism of Kallistatin and PEDF in tumors	20
Odors and cancer: Current status and future directions	19
Molecular and immune pathobiology of human angiosarcoma	19
Improving the efficacy of anti-EGFR drugs in GBM: Where we are going?	19
Dietary and serum advanced glycation end-products and clinical outcomes in breast cancer	19
The role of TRIM25 in the occurrence and development of cancers and inflammatory diseases	19

TERT promoter mutations in gliomas: Molecular roles in tumorigenesis, metastasis, diagnosis, prognosis, therapeutic targeting, and drug resistance	19
Epigenetic mechanisms of cancer progression and therapy resistance in estrogen-receptor (ER+) breast cancer	19
Cyclin-dependent kinases in DNA damage response	19
Protein induced by vitamin K absence or antagonist II: Experience to date and future directions	19
The potential of TRP channels as new prognostic and therapeutic targets against prostate cancer progression	19
Biological function, regulatory mechanism, and clinical application of mannose in cancer	19
Unveiling Cuproptosis: Mechanistic insights, roles, and leading advances in oncology	19